alternative titration semaglutide Can you alternate and tirzepatide? Alternative dosing regimens of GLP‐1

Medication Safety Screening Certain risksthough uncommonare clinically significant: History of pancreatitis Thyroid C-cell pathology (e.g., medullary thyroid carcinoma risk) Severe renal impairment While not all of these are detected solely through lab tests, labs provide essential context for risk stratification

These factors should inform provider discussions, not replace medical judgment

Monitoring : Whatever you choose, plan follow-up, labs and realistic milestones for measuring benefit and side effects

Average weight loss typically ranges from 8 to 12 pounds over 52 weeks representing 2 to 4% of body weight

Second, BP was not the primary endpoint in most of the included studies, so all reported BP data must be treated with caution